• Drugs of Abuse Analysis Gets Automated with New Spe Instrumentation


Drugs of Abuse Analysis Gets Automated with New Spe Instrumentation

Apr 05 2007

The new Gilson GX ASPEC Instrument range, from Anachem provides total handling for patient sample analysis. From simple liquid handling tasks such as dilution and buffer addition, to complex heating and derivatisation procedures, automated SPE and fraction collection. Sample dry down and injection onto the GC can also be automated with the help of ASPEC.

The ASPEC units incorporate large cartridge capacities and pressure sensing modules to ensure constant system performance in demanding laboratories. The revolutionary JetWash rinse stations vastly reduce risks of carryover or contamination between samples, ensuring maximum integrity of patient results. Combining throughput, minimal linear bench space usage plus the ability to run unattended, the GX ASPEC is the perfect choice for sample preparation in drugs of abuse analyses.

GX ASPEC is available as a single probe instrument (GX-271) or for larger centres a four probe instrument (GX-274) is capable of processing up to four samples simultaneously, increasing throughput and efficiency.

Each instrument utilizes 1, 3 and 6ml SPE cartridges and an innovative sealing cap technology based on positive pressure elutions, enables cartridges to be sealed, run and monitored separately. The GX modular design allows for the use of code 20, 200 and 300 series racks and both the GX-271 and GX-274 ASPEC are controlled using Gilson's Trilution? LH 2.0 software.

Digital Edition

MAC Guide 2023/24

December 2023

Buyers Guide - Major producers of analytical equipment who wish to introduce and sell their products to buyers in science and industry - Over 1,000 products and services that these companys man...

View all digital editions


Instrumentation Live

Jan 17 2024 Birmingham, UK

Smart Factory Expo 2023

Jan 24 2024 Tokyo, Japan

Arab Health

Jan 29 2024 Dubai, UAE

Nano Tech 2024

Jan 31 2024 Tokyo, Japan

SLAS 2024

Feb 03 2024 Boston, MA, USA

View all events